Pe­ter Thiel's Mithril leads ef­fort to elect a new slate of in­sid­ers to the board of trou­bled Covid play­er Ada­gio

Some of the biggest back­ers be­hind the trou­bled $750 mil­lion Covid start­up Ada­gio are mak­ing a move to get a new slate of in­sid­ers on­to the biotech’s board. And they won’t have to stretch much to make that hap­pen.

The group — which in­cludes the high-pro­file Pay­Pal/Face­book bil­lion­aire Pe­ter Thiel and his long­time as­so­ciate at Mithril, Ajay Roy­an, as well as Adimab, run by ex-CEO and Ada­gio founder Till­man Gern­gross — con­trols 48.6% of the stock.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER